Combination of Venetoclax and Ibrutinib Increases bcl2-Dependent Apoptotic Priming, Reduces ITK-Phosphorylation and Is Clinically Promising in Relapsed/Refractory T-Prolymphocytic Leukemia

C. Kornauth , C. Herbaux , B. Boidol , C. Guillemette , P. Caron , S. Poulain , O. Tournilhac (1) , M.E. Mayerhoefer , U. Jaeger , S. Kubicek , M.S. Davids , P.B. Staber

1 CHELTER - Role of intra-Clonal Heterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias

Domaines: Hématologie

C. Kornauth, C. Herbaux, B. Boidol, C. Guillemette, P. Caron, et al.. Combination of Venetoclax and Ibrutinib Increases bcl2-Dependent Apoptotic Priming, Reduces ITK-Phosphorylation and Is Clinically Promising in Relapsed/Refractory T-Prolymphocytic Leukemia. 61st Annual Meeting and Exposition of the American Society of Hematology, Dec 2019, Orlando, United States. 134 (Suppl 1), pp.3965, 2019, Blood. ⟨hal-02427551⟩